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Abstract
OBJECTIVE: The purpose of this study was to test the efficacy of a tailored motivational interviewing (MI)
intervention versus usual care for improving HF self-care behaviors, physical HF symptoms and quality of life.
METHODS: This is a single-center, randomized controlled trial. Participants were enrolled in the hospital.
Immediately after discharge, those in the intervention group received a single home visit and 3-4 follow-up
phone calls by a nurse over 90 days.
RESULTS: A total of 67 participants completed the study (mean age 62±12.8 years), of which 54% were
African American, 30% were female, 84% had class III/IV symptoms, and 63% were educated at a high school
level or less. There were no differences between the groups in self-care maintenance, self-care confidence,
physical HF symptoms, or quality of life at 90 days.
CONCLUSION: Patients who received the MI intervention had significant and clinically meaningful
improvements in HF self-care maintenance over 90 days that exceeded that of usual care.
PRACTICE IMPLICATIONS: These data support the use of a nurse-led MI intervention for improving HF
self-care. Identifying methods to improve HF self-care may lead to improved clinical outcomes.
Keywords
Aged, Chronic Disease, Counseling, Female, Heart Failure, Humans, Male, Middle Aged, Motivational
Interviewing, Patient Education as Topic, Prospective Studies, Quality of Life, Self Care, Self Efficacy, Single-
Blind Method, Treatment Outcome
Disciplines
Cardiology | Cardiovascular Diseases | Circulatory and Respiratory Physiology | Health and Medical
Administration | Health Services Administration | Health Services Research | Medical Humanities | Medicine
and Health Sciences | Nursing | Preventive Medicine
Author(s)
Ruth Masterson-Creber, Megan Patey, Christopher S. Lee, Amy Kuan, Corrine Y. Jurgens, and Barbara Riegel
This journal article is available at ScholarlyCommons: https://repository.upenn.edu/nrs/121
Motivational interviewing to improve self-care for patients with 
chronic heart failure: MITI-HF randomized controlled trial
Ruth Masterson Creber, PhD, MSc, RN1,*, Megan Patey, MSN, WHNP-BC, RN2, Christopher 
S. Lee, PhD, RN, FAHA, FAAN, Amy Kuan, BSN, RN, Corrine Jurgens, PhD, RN, FAAN, and 
Barbara Riegel, PhD, RN, FAHA, FAAN
1School of Nursing, Columbia University, School of Nursing, New York, New York, USA
2School of Nursing, University of Pennsylvania, School of Nursing, Philadelphia, PA, USA
3School of Nursing, Oregon Health & Sciences University, School of Nursing, Portland, Oregon, 
USA
4School of Nursing, University of Pennsylvania, School of Nursing, Philadelphia, PA, USA
5School of Nursing, Stony Brook University, School of Nursing, Stony Brook, NY, USA
6School of Nursing, University of Pennsylvania, School of Nursing, Philadelphia, PA, USA
Abstract
Objective—The purpose of this study was to test the efficacy of a tailored motivational 
interviewing (MI) intervention versus usual care for improving HF self-care behaviors, physical 
HF symptoms and quality of life.
Methods—This is a single-center, randomized controlled trial. Participants were enrolled in the 
hospital. Immediately after discharge, those in the intervention group received a single home visit 
and 3–4 follow-up phone calls by a nurse over 90 days.
Results—A total of 67 participants completed the study (mean age 62 ± 12.8 years), of which 
54% were African American, 30% were female, 84% had class III/IV symptoms, and 63% were 
educated at a high school level or less. There were no differences between the groups in self-care 
maintenance, self-care confidence, physical HF symptoms, or quality of life at 90 days.
Conclusion—Patients who received the MI intervention had significant and clinically 
meaningful improvements in HF self-care maintenance over 90 days that exceeded that of usual 
care.
Practice Implications—These data support the use of a nurse-led MI intervention for 
improving HF self-care. Identifying methods to improve HF self-care may lead to improved 
clinical outcomes.
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Heart failure (HF) affects more than 5.7 million Americans [1] and costs the United States 
$39.2 billion annually [2]. HF is currently the most common reason for the hospitalization of 
Medicare recipients [3–6]. The costs for preventable readmissions are estimated to be about 
$17 billion or 20% of Medicare’s hospital payments [7]. Patients with HF are frequently 
admitted to the hospital because they experience exacerbations in symptoms with fluid 
retention, shortness of breath, and fatigue on exertion [8]. Considering the increasing 
prevalence, cost and social burden to patients and their families, interventions that 
incorporate self-care with effective medical therapy are critical to optimize patient health 
and improve patient outcomes [9–11].
The Situation-Specific Theory of Heart Failure Self-Care specifies three unique aspects of 
HF self-care: maintenance (routine behaviors associated with treatment adherence), 
symptom perception (body listening, monitoring, recognition, interpretation and labeling of 
symptoms) and management (response to symptoms) [12–14]. Confidence or self-efficacy 
has been shown to be an important element contributing to success in the performance of 
self-care [15]. Effective self-care behaviors have the potential to reduce hospitalizations and 
improve quality of life. Several studies have examined the impact of self-care interventions 
on patient-oriented and clinical outcomes including self-care behaviors [16], self-efficacy 
[17], quality of life [17–20], physical activity [21], health status [22], hospitalizations [23, 
24], mortality [20], myocardial stress [25] and systemic inflammation [26]. Overall, there 
has been an apparent lack of effectiveness of education alone on outcomes related to HF 
self-care. One reason is that patients face a number of prohibitive barriers to mastering HF 
self-care skills and knowledge, including cognitive impairment, excessive daytime 
sleepiness, low-health literacy [27–29], and poor motivation [30]. One suggested approach 
is to use motivational interviewing (MI) [16, 31], a counseling approach grounded in client-
centered counseling, cognitive-behavioral therapy, and social cognitive therapy [32]. MI 
assesses a patient’s readiness to change behavior and develops strategies to move toward 
taking action to change behavior [33].
The purpose of this randomized controlled trial (Motivational Interviewing Tailored 
Intervention for Heart Failure [MITI-HF]) was to test a tailored MI intervention designed to 
improve self-care compared with usual care. The main hypothesis was that HF patients 
enrolled in the group receiving the tailored MI intervention would improve in self-care 
maintenance after 90 days. Secondary outcomes included physical HF symptoms and quality 
of life.
Methods
Study design
MITI-HF was a prospective, single-blinded, randomized controlled trial. The University’s 
Institutional Review Board approved the study. Participants were actively enrolled from 
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January 2012 to December 2013. Detailed description of study methods including 
participant eligibility, recruitment procedures and data collection have been registered 
(Clinicaltrials.gov ID: NCT02177656), reported in a study design paper [34] and are 
summarized here. The target recruitment size was 66 participants, a sample size calculated 
to provide 90% power (5% alpha) to detect a difference of 80% versus 50% (intervention 
and control group) in the likelihood of scoring over 70 on the self-care maintenance scale in 
the Self-Care of Heart Failure Index (SCHFI) v.6.2 at 90 days. The estimated attrition was 
35%, based on previous studies in this population [16], so participants were overenrolled to 
account for anticipated attrition. The power analysis was performed using G*Power [35] and 
confirmed with PASS [36].
Procedure
Potential participants were approached during an inpatient HF-related hospitalization at a 
University affiliated urban hospital. The study inclusion and exclusion criteria are shown in 
Table 1. All eligible patients were screened for health literacy [37], cognitive impairment 
(using a six-item screener derived from the Mini Mental Status Exam) [38], baseline self-
care (using the SCHFI v.6.2) [39], and symptomatic status (using a standardized interview to 
assess New York Heart Association (NYHA) functional class) [40]. Health literacy was 
measured with three screening questions (e.g., “How often do you have someone help you 
read hospital materials?”) [37]. Responses of never, occasionally, sometimes, often, always 
are scaled 0 to 4. These questions have been shown to be sensitive to poor health literacy in 
multiple patient populations (receiver operating curves (0.87, 0.80, 0.76)) [37, 41].
Participant characteristics of age, gender, co-morbid conditions, prescribed medications, 
diagnostic lab tests, and echocardiogram results were obtained from the medical record. 
During baseline interviews research assistants obtained information from the participant on 
race/ethnicity, insurance status, years of education, perceived and self-rated health compared 
to one-year ago. Participants were also asked about the quality of their social support and 
responses included fair, satisfactory, good or very good. Traditional questions about income 
characteristics (sources, amounts received) have been wrought with a wide range of bias 
[42] and random error [43], so income was measured with the question, “Financially, would 
you say you are: comfortable; have more than enough to make ends meet; have enough to 
make ends meet; or do not have enough to make ends meet?”
Those who met the inclusion criteria and agreed to participate provided written informed 
consent. To standardize care across the groups, all participants received a set of educational 
fliers described further below. Participants were then randomized by minimization [44] with 
stratification by NYHA functional class and gender to the intervention or control group in a 
2:1 randomization ratio [45].
Baseline data were collected approximately two weeks after hospital discharge. Two 
research assistants (blinded to study group allocation) called participants to obtain socio-
demographic information and to administer the baseline questionnaires. If participants did 
not complete the baseline data collection they were not enrolled in the study. Approximately 
90 days after the baseline call, participants in both groups were called to complete all of the 
follow-up questionnaires. If the first follow-up call was unsuccessful, the research assistant 
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would try every 3 to 5 days for up to 60 days. If there was no contact with the participant 
after 60 days from the expected follow-up date, the participant was considered lost to 
follow-up.
Usual Care
Individuals randomized to the usual care group received care as usual from their respective 
care providers. To standardize care across the study groups all participants received patient 
education materials designed by Krames StayWell. These materials were designed to assist 
patients to identify and address self-care barriers, maintain a lower sodium diet, and lead an 
active lifestyle. All of the educational sheets targeted goal behavior changes through 
participant interaction, such as writing down the names of support people who would help 
them see habits that might block their progress toward change.
Intervention Description
As described in detail elsewhere [46], participants assigned to the intervention group 
received an MI tailored intervention that included a home-based MI intervention and 3–4 
follow-up phone calls over the course of 90 days. During the home visit the nurse worked 
with the participant using an MI approach to identify at least two specific client-centered 
goals related to HF self-care. After establishing the client-directed plan for accomplishing 
the goals it was reinforced in the follow-up phone calls. For example, if a participant said 
that one of his goals was to be able to attend his grandson’s football games in the fall, the 
nurse tailored the intervention around smaller daily goals focused on improving physical 
activity. The day-to-day self-care goals were considered relevant to the participant because 
they were contextualized as part of his self-defined goal of attending his grandson’s football 
games.
Study Outcome Measures
Self-care—Self-care was measured using the SCHFI v. 6.2, a 22-item instrument that 
quantifies HF self-care maintenance, self-care management, and self-care confidence (self-
efficacy) [14, 39]. The SCHFI was written for a sixth grade reading level and takes less than 
10 minutes to complete. Scores on each scale are standardized to range from 0 to 100—
higher scores indicate better self-care. A score of 70 or greater on each scale is considered 
adequate and an improvement of 8 points is considered clinically meaningful [39]. The 
reliability coefficient for the self-care maintenance scale is 0.78 [47] and construct validity 
scores are 0.92 for self-care maintenance and 0.99 for self-care confidence [48].
Acute Physical Heart Failure Symptoms—Acute physical HF symptoms were 
measured with the heart failure somatic perception scale (HFSPS), which asks about distress 
associated with 18 common symptoms of HF during the previous week. Responses range 
from 0 (I did not have this symptom) to 5 (extremely bothersome) [49]. The total HFSPS 
score ranges from 0 to 90 with higher scores indicating worse physical symptom distress 
[50]. In addition to the total score, which has good reliability (Cronbach’s α 0.90) [51], the 
scale also has two separate domains, dyspnea (6-items, range 0–30 points) and early/non-
specific symptoms of congestion (7-items, range 0–35 points), both of which are associated 
with survival at 180 and 365-days [50].
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Quality of life—Quality of life was measured with the Kansas City Cardiomyopathy 
Questionnaire (KCCQ), which has 23 items that can be quantified into five subscales: 
physical limitations, symptoms, quality of life, social interference, and self-efficacy. Each 
domain-specific subscale and the overall clinical summary score range from 0 to 100 (higher 
scores indicate better outcomes) [52]. In a comparable sample of patients with heart failure, 
the internal consistency of the KCCQ was high (Cronbach’s α 0.92) [53]. Construct validity 
has been established with NYHA class, Medical Outcomes Study Short Form-36 Health 
Survey and the six minute-walk-test [52].
Data Analysis
Standard descriptive statistics were used to describe all study covariates at baseline. Chi 
square and student’s t-tests were used to examine differences based on group assignment. 
Baseline demographic and clinical characteristics between the two study groups were 
assessed to determine adequacy of randomization. Response bias was assessed by 
comparing participants who completed the study to those who were lost to follow-up. 
Students t-tests were used to assess for change in self-care maintenance and self-care 
confidence, physical HF symptoms and quality of life between baseline and 90 days 
between groups. Cohen’s d was calculated as a standardized index of effect sizes.
For the primary outcome (self-care maintenance) a model comparison approach [54] was 
applied throughout the model building process including a priori factors (gender, age, 
NYHA class, race, marital status, left ventricular ejection fraction (LVEF) and having a 
home care nurse) and covariates associated in bi-variate analyses with the outcome variable 
(p<0.05). Factors that were considered in the models but were not significant and did not 
contribute to the robustness of the model were removed systematically using a manual 
backwards elimination process. The final multiple linear regression model for predictors of 
change in self-care maintenance included the following variables: intervention group, 
LVEF, sleep apnea, gender, hypertension, perceived general health and quality of social 
support. These seven variables were adjusted in the main analyses of group differences over 
time. Statistical interactions by group and gender were also evaluated. Data analyses were 
conducted using StataSE 13.1 (College Station, Texas).
Results
The CONSORT diagram (Figure 1) reflects participants who were screened, enrolled, 
randomized and included in the analyses for self-reported outcomes between the two groups. 
A total of 100 participants were enrolled and 67 completed the study of self-reported 
outcomes. The overall attrition rate was 33% (n=33), (13% in the usual care group and 42% 
in the intervention group) consistent with other studies of patients with HF [55]. There were 
no statistically significant differences in the socio-demographic or clinical characteristics of 
participants who completed versus did not complete the study. There were also no 
statistically significant differences in the self-care, physical HF symptom or quality of life at 
baseline between those who completed and did not complete the study. Thus, there was no 
evidence to suggest a violation of the missing at random assumption.
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Participants who completed the study were predominantly male (60%) and African 
American (>50%) with a mean age of 62 years. The majority was functionally compromised 
(83.6% NYHA Class III/IV) with a mean left ventricular ejection fraction (LVEF) < 36 
percent (Tables 2a & 2b). Most participants had no more than a high school education and 
reported poor or fair health. Participants were on an average of 12 daily medications and had 
an average of 5.5 comorbid conditions.
Self-care Maintenance and Confidence
There was overall improvement in self-care maintenance in both groups over 90 days 
(intervention: 19.7 ± 16.0, usual care: 12.1 ± 18.3) (Table 3). The improvement in self-care 
maintenance was numerically greater in the intervention group compared with usual care 
(Figure 2). Though the effect size was moderate (Cohen’s d= 0.44), the difference between 
groups was not initially statistically significant. After adjusting for intervention group, 
LVEF, sleep apnea, gender, hypertension, perceived general health and quality of social 
support, there was a statistically significant 8.7-point increase (95% CI: 1.1 – 16.3, p=0.026) 
in the MI group compared to the usual care group at 90 days (Table 4). Patients with sleep 
apnea (β=17.9, p=0.020), worse perceived general health (β=13.5, p=0.002), or worse social 
support (β=10.6, p=0.042) also improved in self-care maintenance over 90-days after 
adjusting for other factors. In addition, for each unit increase in LVEF, the change in self-
care maintenance decreased 0.32 points. There was no evidence of interactions by study 
group or gender.
In both groups, self-care confidence improved more than 20 points, although the absolute 
change in self-care confidence was numerically higher in the intervention group compared 
with usual care (Cohen’s d=0.26) (Table 3). There were no statistically significant 
differences in improvement in self-care confidence between the two study groups (p=0.31).
Physical HF symptoms and quality of life
At 90 days, the sample mean HFSPS was 17.9 ± 18.1 with no differences between groups 
(p=0.63). For the early and non-specific symptoms of congestion scale and dyspnea sub-
scales there were also no differences between groups. The difference in quality of life 
between groups was not significantly different between the groups (p=0.36) (Figure 2).
Discussion
The results of this randomized controlled trial designed to test the efficacy of a tailored MI 
intervention show that although there were no differences in the univariate analysis, there 
was a trend towards improved self-care maintenance for patients who received the MI 
intervention. These results support our hypothesis that motivating people with HF to take 
more control over their health using MI can help them achieve improved self-care [56].
Our results are similar to those of Ogedegbe and colleagues who tested whether 
hypertensive African American patients randomized to patient education alone or MI would 
have improved adherence to prescribed anti-hypertensive medication, one element of self-
care maintenance [57, 58]. Their results demonstrated more improvement in medication 
adherence assessed with an electronic event-monitoring device over 12 months in the MI 
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intervention compared to the control group [58], consistent with our results. The consistency 
in results between these two studies may be attributed to some similarities in study design, 
including the same number of MI sessions, similar racial demographics and a focus on a 
cardiovascular disease with a shared pathophysiology. Together, these studies suggest a 
benefit of using MI as a behavioral intervention for African American patients with 
hypertension and heart failure.
The MITI-HF results differ from those of the Osteoporosis Telephonic Intervention to 
Improve Medication Adherence (OPTIMA) trial. OPTIMA investigators examined the 
effectiveness of an MI based telephone-based counseling program to improve adherence to 
the medication regimen for osteoporosis [59]. These investigators found no significant 
improvement in medication adherence measured electronically. In addition to different 
patient populations, there are a few other critical differences between MITI-HF and 
OPTIMA that may explain the differences in results. As suggested by Lavoie in a letter to 
the editor regarding OPTIMA, one key tenet of behavioral trial design is targeting 
participants with evidence of poor behavior at the beginning of the trial [60]. As a pragmatic 
trial, OPTIMA enrolled any patient who received a new prescription regardless of baseline 
adherence. Some patients without problems with adherence were enrolled and this could 
have diluted the treatment effect. Participants enrolled in MITI-HF were all patients who 
had been hospitalized and reported “never/rarely” or only “sometimes” performing at least 
one or two self-care maintenance behaviors. Secondly, each of the 10 counseling sessions in 
the OPTIMA study had pre-specified educational topics which included a series of open-
ended questions to elicit subjects’ attitudes and barriers [59]. In contrast, consistent with the 
MI approach, each of the counseling sessions in MITI-HF was driven by participant 
preference.
In MITI-HF, the MI intervention did not improve participants’ self-care confidence (self-
efficacy) over time compared with usual care. In contrast, there is early evidence from a 
study by Paradis and colleagues that reports improvement in self-efficacy using an MI 
approach in patients with HF [61]. In the Paradis study, patients received a similar dose of 
MI from a nurse (one face-to-face MI intervention followed up by two telephone 
conversations). They reported no improvement in self-care maintenance but an improvement 
in self-care confidence after one month. Differences in study design between these two 
studies may explain the differences in self-care outcomes, including length of patient follow-
up (30 versus 90 days) and at least one or two more follow-up MI phone calls in MITI-HF.
In MITI-HF, quality of life improved in both study groups over 90 days; however, there 
were no statistically significant differences between groups. This improvement, regardless 
of group, may reflect the known improvement in quality of life after discharge from an acute 
hospitalization. Consistent with MITI-HF, a study by Chair and colleagues tested MI in 
patients diagnosed with coronary heart disease in Hong Kong. They reported improvement 
in health-related quality of life across all subscales of the Medical Outcomes short-form-36 
(SF-36) in both the MI and usual care groups with no differences between them [62]. The 
Chair study also reported no changes in clinical outcomes between groups (systolic or 
diastolic blood pressure, body mass index, multiple measures of cholesterol and 
triglycerides); however unlike MITI-HF, self-care was not measured except for medication 
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adherence [62]. In another study of patients with HF randomized to a MI physical activity 
intervention or usual care, the results were mixed for changes in quality of life measured 
with both the SF-36 and Minnesota Living with Heart Failure questionnaire [17]. Overall, 
the results from all three studies of patients with cardiovascular diseases report similar 
findings. MI alone is most likely not enough to improve the quality of life of patients who 
are severely ill with chronic cardiovascular disease. This is not surprising given that these 
interventions were focused on specific aspects of self-care and a wide array of complex 
factors influence quality of life, which were not addressed in these studies. It is also possible 
that in a functionally compromised population of patients with severe HF that there is a 
ceiling effect of how much quality of life can improve over time due to the impact of 
worsening disease severity.
Limitations
A major limitation of the MITI-HF, a nurse-led intervention that included one inhome visit 
and 3–4 follow-up calls over a 90-day period, was the loss of participants to follow-up and 
specifically the difference in attrition for the self-reported outcomes between the usual care 
and MI group. One of the proposed reasons for differential dropout was that the MI group 
had at least 60% more points of contact than the usual care group, thus increasing 
opportunities for dropout. A consideration for evaluating a similar intervention in a future 
study would be to alter the number of, or duration between, points of contact in order to 
address the issue of dropout. In future studies, we will also collect feedback from 
participants who decline to participate to gain insight into reasons for declining 
participation. Another limitation was that objective measures of self-care behaviors (e.g. 
pedometer for exercise) were not used in this study. All of the comorbid conditions were 
abstracted from the medical record so the prevalence of depression and anxiety may also be 
underestimated in the sample.
Strengths of MITI-HF include high minority participation (over 50%), with women well 
represented. Future research is needed to determine if a similarly designed nurse-led MI 
intervention can be effective and cost-effective if implemented in a clinical practice setting 
rather than in the home.
Conclusion
This study reports a novel nurse-led behavioral intervention that uses MI to help patients 
with HF improve their self-care. Although there was no statistically significant difference in 
the primary outcome over 90-days, there was a clinically significant difference after 
adjusting for confounding factors.
Practice Implications
More work is still needed to identify which behavioral interventions improve clinical and 
patient-oriented outcomes for patients with HF. However, MI does appear to be a promising 
approach. Healthcare providers should consider incorporating MI into consultations with 
patients.
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Highlights
• Clinically significant difference in self-care maintenance in the MI group
• MI is a promising approach for improving self-care maintenance
• No difference between groups in physical HF symptoms or quality of life
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Figure 1. 
CONSORT diagram.
Creber et al. Page 14
Patient Educ Couns. Author manuscript; available in PMC 2017 February 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 2. 
Absolute change in outcomes at baseline and 90-days in the intervention and usual care 
groups.
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Table 1
Eligibility Criteria.
Inclusion Criteria Exclusion Criteria
1 Hospitalized with a primary or secondary diagnosis of HF milrinone
2 Able to read and speak English or heart transplant
3 18 years of age or older
4 Living in a setting where they independently engage in self-care
5 Living within 30 miles from the University Hospital inability to pass the six-
item screener
6 Have at least adequate health literacy
7 Symptomatic HF (NYHA II–IV) consent
1 Current treatment with
2 On a list for an implanted VAD
3 Pregnancy
4 Psychosis
5 Cognitive impairment- the or 
complete study instruments
6 Inability to provide informed
Abbreviations: HF: heart failure, NYHA: New York Heart Association, VAD: ventricular assist device
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Table 2
a. Baseline socio-demographic characteristics by randomization group
Randomization group (mean +/− SD or %)
Variables Overall
Total (N=67)
Control
Total (N=26)
Intervention
Total (N=41)
p-value
Age 62 (13.4) 63 (12.6) 60 (13.9) 0.397
Gender 0.130
  Female 20 (29.9) 5 (19.3) 15 (36.6)
  Male 47 (70.2) 21 (80.8) 26 (63.4)
Married/Partnered 31 (46.3) 15 (57.7) 16 (39.0) 0.135
Race 0.128
  Black 36 (53.7) 17 (65.4) 19 (46.3)
  White 31 (46.3) 9 (34.6) 22 (53.7)
Education 0.233
  ≤High School 42 (62.7) 14 (53.9) 28 (68.3)
  College/Grad School 25 (37.3) 12 (46.2) 13 (31.7)
  Total years education 13 (2.3) 13 (2.2) 13 (2.4)
Employment Status 0.834
  Employed/Retired 32 (47.8) 12 (46.2) 20 (48.8)
  Unemployed/Disabled 35 (52.2) 14 (53.9) 21 (51.2)
Financial Status 0.435
  Comfortable/Enough 45 (67.2) 16 (61.5) 29 (70.7)
  Not enough 22 (32.8) 10 (38.5) 12 (29.3)
Insurance Type 0.419
  Government 50 (74.6) 18 (69.2) 32 (78.1)
  Commercial 17 (25.4) 8 (30.8) 9 (22.0)
Health Perception 0.088
  Poor/Fair 49 (73.1) 16 (61.5) 33 (80.5)
  Good/Very Good/Excellent 18 (26.9) 10 (38.5) 8 (19.5)
Health in General 0.746
  Worse/Same 37 (55.2) 15 (57.7) 22 (53.7)
  Better/Much Better 30 (44.8) 11 (42.3) 19 (46.3)
Home Health Nurse 49 (73.1) 18 (69.2) 31 (75.6) 0.566
Provider Specialty 0.292
  Medicine/Cardiology 16 (23.9) 8 (30.8) 8 (19.5)
  HF Specialist 51 (76.1) 18 (69.2) 33 (80.5)
Lives with another 51 (76.1) 21 (80.8) 30 (73.2) 0.477
Support Quality 0.241
  Fair/Satisfactory 11 (16.4) 6 (23.1) 5 (12.2)
  Good/Very Good 56 (83.6) 20 (76.9) 36 (87.8)
Nurse Interventionist 0.902
  Nurse 1 51 (76.1) 20 (76.9) 31 (75.6)
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a. Baseline socio-demographic characteristics by randomization group
Randomization group (mean +/− SD or %)
Variables Overall
Total (N=67)
Control
Total (N=26)
Intervention
Total (N=41)
p-value
  Nurse 2 16 (23.9) 6 (23.1) 10 (24.4)
b. Baseline clinical factors by randomization group
Randomization group (mean +/− SD or %)
Variables Overall
Total (N=67)
Control Total
(N=26)
Intervention
Total (N=41)
p-value
NYHA Functional Class 0.125
  Class I/II 11 (16.4) 2 (7.7) 9 (22.0)
  Class III/IV 56 (83.6) 24 (92.3) 32 (78.1)
HF Etiology 0.743
  Ischemic 23 (36.5) 9 (39.1) 14 (35.0)
  Non-ischemic 40 (63.5) 14 (60.9) 26 (65.0)
HF Type 0.419
  Systolic 50 (74.6) 18 (69.2) 32 (78.1)
  Diastolic 17 (25.4) 8 (30.8) 9 (22.0)
Ejection Fraction (%) 36 (18.14) 39 (17.9) 35 (18.3) 0.393
Charlson Comorbidity Index 0.420
  Low (1–2) 15 (22.4) 8 (30.8) 7 (17.1)
  Medium (3–4) 34 (50.8) 12 (46.2) 22 (53.7)
  High (5–11) 18 (26.9) 6 (23.1) 12 (29.3)
Pacemaker (any type) 21 (31.3) 8 (30.8) 13 (31.7) 0.936
Medications (total) 12 (5.5) 12 (5.6) 12 (5.6) 0.782
  Beta Blocker 57 (85.1) 24 (92.3) 33 (80.5) 0.186
  Ace Inhibitor/ARB 39 (58.2) 15 (57.7) 24 (58.5) 0.725
  Statin 40 (59.7) 16 (61.5) 24 (58.5) 0.807
  Diuretic 59 (88.1) 23 (88.5) 36 (87.8) 0.936
Baseline Lab Values
  Sodium 135.7 (15.6) 137.6 (2.8) 134.5 (19.9) 0.434
  Hemoglobin 11.6 (1.9) 11.8 (1.8) 11.4 (1.9) 0.370
  BUN/Creatinine ratio 20.6 (10.4) 17.5 (10.0) 22.5 (10.3) 0.056
Comorbid conditions
  Hypertension 47 (70.2) 20 (76.9) 27 (65.9) 0.335
  Atrial Fibrillation 21 (31.3) 9 (34.6) 12 (29.3) 0.646
  Diabetes 33 (49.2) 12 (46.1) 21 (51.2) 0.686
  Renal Disease 43 (64.2) 15 (57.7) 28 (68.3) 0.378
  COPD 10 (14.9) 2 (7.7) 8 (19.5) 0.186
  Depression 3 (4.9) 0 3 (7.3) 0.158
  Chronic pain 7 (10.5) 4 (15.4) 3 (7.3) 0.293
Abbreviations HF: heart failure, NYHA: New York Heart Association, ARB: Angiotensin II Receptor Blockers,
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BUN:blood urea nitrogen,
COPD: chronic obstructive pulmonary disease
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Table 3
Mean changes in outcomes from baseline to 90-days in the intervention and usual care groups (n=67).
Variable Intervention
mean (SD)
Usual care
mean (SD)
t-value (p)
Self-care maintenance 19.7 (16.0) 12.1 (18.3) −1.8 (0.08)
Self-care confidence 26.6 (20.8) 21.6 (16.8) −1.0 (0.31)
HFSPS Total Score −2.8 (16.8) −0.73 (17.1) 0.5 (0.63)
KCCQ QOL 10.8 (28.2) 4.81 (21.4) 0.9 (0.36)
KCCQ CSS 9.3 (23.9) 11.86 (20.9) 0.4 (0.67)
Abbreviations: SD: standard deviation; HFSPS: heart failure somatic perception scale; KCCQ: Kansas City Cardiomyopathy Questionnaire, QOL: 
quality of life, CSS: clinical summary score.
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Table 4
Multiple linear regression model for predictors of change in self-care maintenance from baseline to 90-days 
(n=67).
Independent Variables β-
coefficient
SE 95% CI p-value
Intervention (ref control) 8.69 3.80 (1.09 to 16.30) 0.026
Left ventricular ejection fraction −0.32 0.11 (−0.53 to −0.11) 0.004
Sleep apnea (ref no sleep apnea) 17.85 5.58 (6.67 to 29.02) 0.002
Gender (ref male) −1.80 4.22 (−10.25 to 6.64) 0.671
Perceived general health (ref better health) 13.49 3.80 (5.86 to 20.77) 0.002
Hypertension (ref no hypertension) 7.80 4.15 (−0.50 to 16.11) 0.065
Quality of social support (ref good/very good) 10.55 5.01 (0.43 to 20.78) 0.042
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